LeadIQ logo
Learn more at LeadIQ.com

Insights

Executive Leadership Replimune recently appointed Sushil Patel, Ph.D., as the new CEO and Madhavan Balachandran to its Board of Directors, showcasing a reinvigorated leadership team that may present opportunities for partnership discussions.

Funding & Expansion Having secured approximately $100 million in financing through a PIPE deal, Replimune is in a strong financial position for growth and potential collaborations, making it an attractive target for business development initiatives.

Product Launch Replimune's launch of its lead product candidate, RP1, signals an exciting milestone that could drive market interest, presenting sales opportunities for strategic partnerships or investor engagement.

Experienced CFO With the recent appointment of Emily Hill as Chief Financial Officer, Replimune has strengthened its financial leadership, potentially fostering investor confidence and creating avenues for financial collaborations.

Market Position Positioned among peers like Transgene, OSE Immunotherapeutics, and 4D Molecular Therapeutics, Replimune's revenue range and innovative therapies make it a compelling player for potential market collaborations or competitive positioning strategies.

Similar companies to Replimune

Replimune Tech Stack

Replimune uses 8 technology products and services including SAS/GRAPH, Veeva Vault, Modernizr, and more. Explore Replimune's tech stack below.

  • SAS/GRAPH
    Business Intelligence
  • Veeva Vault
    Enterprise Content Management
  • Modernizr
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • jQuery Mobile
    Mobile Frameworks
  • Python
    Programming Languages
  • ARGUS
    Real Estate Marketing
  • Contact Form 7
    Web Platform Extensions

Media & News

Replimune's Email Address Formats

Replimune uses at least 1 format(s):
Replimune Email FormatsExamplePercentage
First.Last@replimune.comJohn.Doe@replimune.com
91%
First@replimune.comJohn@replimune.com
5%
FirstLast@replimune.comJohnDoe@replimune.com
3%
FirstL@replimune.comJohnD@replimune.com
1%

Frequently Asked Questions

Where is Replimune's headquarters located?

Minus sign iconPlus sign icon
Replimune's main headquarters is located at Woburn, MA 01801 US. The company has employees across 2 continents, including North AmericaEurope.

What is Replimune's stock symbol?

Minus sign iconPlus sign icon
Replimune is a publicly traded company; the company's stock symbol is REPL.

What is Replimune's official website and social media links?

Minus sign iconPlus sign icon
Replimune's official website is replimune.com and has social profiles on LinkedIn.

How much revenue does Replimune generate?

Minus sign iconPlus sign icon
As of September 2024, Replimune's annual revenue reached $35M.

What is Replimune's SIC code NAICS code?

Minus sign iconPlus sign icon
Replimune's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Replimune have currently?

Minus sign iconPlus sign icon
As of September 2024, Replimune has approximately 326 employees across 2 continents, including North AmericaEurope. Key team members include Chief Development Operations Officer, Replimune: T. L.Chief Information Officer: D. K.Chief Commercial Officer: C. S.. Explore Replimune's employee directory with LeadIQ.

What industry does Replimune belong to?

Minus sign iconPlus sign icon
Replimune operates in the Biotechnology Research industry.

What technology does Replimune use?

Minus sign iconPlus sign icon
Replimune's tech stack includes SAS/GRAPHVeeva VaultModernizrUnderscore.jsjQuery MobilePythonARGUSContact Form 7.

What is Replimune's email format?

Minus sign iconPlus sign icon
Replimune's email format typically follows the pattern of . Find more Replimune email formats with LeadIQ.

How much funding has Replimune raised to date?

Minus sign iconPlus sign icon
As of September 2024, Replimune has raised $155M in funding. .

When was Replimune founded?

Minus sign iconPlus sign icon
Replimune was founded in 2015.
Replimune

Replimune

Biotechnology ResearchMassachusetts, United States201-500 Employees

Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.

Section iconCompany Overview

Headquarters
Woburn, MA 01801 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
REPL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $155M

    Replimune has raised a total of $155M of funding over 2 rounds. .

  • $10M$50M

    Replimune's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $155M

    Replimune has raised a total of $155M of funding over 2 rounds. .

  • $10M$50M

    Replimune's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.